Other Forms of Competition ...There's other forms of competition, not just pouch based. Google "type 1 diabetes cure". Just on the first page, you'll see a bunch of alternative cures. The most exciting one is out of California, they found that dead islet cells such as insulin producing cells, are not operating but not completely dead. Other studies found even after 50 years, some of the insulin islets still working. The scientists in California found a way, using stem-cell research, to reactivate a type 1 diabetics existing insulin producing islets. This would require no cell pouch. Also, this technology might be able to be use for other conditions where ones own islet cells or proteins have died off in limbo, but able to reactivate them. This would eliminate the need for a cell pouch, as people would prefer no device with surgery, if this stem-cell research works. Possibly there would be some islets or proteins for some conditions that won't work with this procedure, but if you knock Type 1 Diabetes off the list of Sernova's curable uses, that's a huge hit to their profit. Also, take a look at the other link, researches in the U.K. have come up with a device the size of wrist watch that's implantable for Type 1 Diabetes. It's ingenious, as it has no mechanical moving parts, rather an expandable material that senses blood sugar levels, and when blood sugar levels increase, it start to expand and slowly release insulin. Then when blood sugar drops, it starts to shrink and stops releasing insulin. Absolutely ingenious, and they're starting human trials in 2016. It requires a monthly refill by injecting once per month, but that inconvenience is the least concern of type 1 diabetics, they just want perfect blood sugar control to avoid complications. This technology would eliminate the need for Sernova's cell pouch for both Type 1 and Type 2 diabetes, as it would assist type 2 diabetics who often have working insulin producing islet cells, rather weakened and less effective insulin absorption. That device would assist those type 2 diabetics with additional insulin. So the profit potential loss for type 1 and type 2 diabetes by the above technologies would be a huge hit for Sernova. They would be left with less profitable uses like Haemopehlia, which stem-cell research might be able to reactivate needed cells for that without a pouch as well. That's the reality and truth. I was sick of not being able to Google diabetes cures because I had money invested in Sernova and didn't want to believe there's other cures out there. I also understand how the stock market works. Usually always a strong pull back when a stock doubles. I might buy back lower, but I'm not going to be blind to the competition and biased just for Sernova technology. Diabetics want the cure, we don't care about the money. The fact is that the cure for diabetes is a race around the world with many different approaches being taken. Which means Sernova is a high risk investment. https://www.gmanetwork.com/news/story/347810/scitech/science/researchers-close-in-on-cure-for-type-1-diabetes https://www.express.co.uk/news/health/455748/Potential-diabetes-cure-to-end-misery-of-insulin-jabs https://www.news-medical.net/health/Type-1-Diabetes-Cure.aspx https://www.medicalnewstoday.com/articles/267241.php